Resumo

GARCIA-MONTOYA, Andrés José  e  BARRERA-ESCOBAR, Sebastián. Acute kidney injury and hemolytic anemia induced by rifampin, an infrequent and deadly complication. Iatreia [online]. 2022, vol.35, n.3, pp.356-360.  Epub 19-Maio-2023. ISSN 0121-0793.  https://doi.org/10.17533/udea.iatreia.145.

Rifampicin is a widely used drug for the treatment of various infectious diseases with a broad spectrum of adverse reaction ranging from mild to life-threatening manifestations; hemolytic anemia is an adverse effect rarely reported in the literature, but it can have a potentially fatal outcome. Thus, we report a case of autoimmune hemolytic anemia associated with acute kidney injury in a young patient in the second phase of treatment for pulmonary tuberculosis.

Palavras-chave : Acute Kidney Injury; Hemolysis; Rifampin.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )